Literature DB >> 18553025

Ventriculitis: a rare case of primary cerebral toxoplasmosis in AIDS patient and literature review.

Gláucia Fernandes Cota1, Elisa Caroline Pereira Assad, Paulo Pereira Christo, Alexandre Varella Giannetti, José Augusto Malheiros Dos Santos Filho, Marcelo Antonio Pascoal Xavier.   

Abstract

Cerebral toxoplasmosis remains the most important neurological opportunistic infection and the most common cause of intracerebral mass lesion in patients with acquired immunodeficiency syndrome (AIDS). We report a case of an adult AIDS patient with an atypical pattern of toxoplasma encephalitis, presenting with ventriculitis and obstructive hydrocephalus without any focal parenchymal lesion.

Entities:  

Mesh:

Year:  2008        PMID: 18553025     DOI: 10.1590/s1413-86702008000100022

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  5 in total

1.  A 31-year-old man with vitritis, chorioretinitis, and hydrocephalus.

Authors:  Andrew J Schneier
Journal:  Digit J Ophthalmol       Date:  2012-05-14

2.  Periventricular hypodensity is associated with the incidence of pre-shunt seizure in hydrocephalic children.

Authors:  Mirna Sobana; Danny Halim; Mulya Nurmansyah Ardisasmita; Akhmad Imron; Uni Gamayani; Tri Hanggono Achmad
Journal:  Childs Nerv Syst       Date:  2022-04-25       Impact factor: 1.532

Review 3.  Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.

Authors:  Veeranoot Nissapatorn; Nongyao Sawangjaroen
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

4.  Cerebral toxoplasmosis combined with disseminated tuberculosis.

Authors:  Eui Ho Hwang; Poong Gi Ahn; Dong Min Lee; Hyeok Su Kim
Journal:  J Korean Neurosurg Soc       Date:  2012-05-31

5.  Ventriculitis and hydrocephalus with hypoglycorrhachia in congenital toxoplasma infection.

Authors:  Ankur Kapoor; Harsimrat Bir Singh Sodhi; Sivashanmugam Dhandapani
Journal:  J Pediatr Neurosci       Date:  2016 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.